Diamondback Energy Inc vs 10X Genomics Inc — how do they compare? Diamondback Energy Inc trades at $200 (market cap $56.48B), while 10X Genomics Inc trades at $59.24 (market cap $7.61B). The key difference: Diamondback Energy Inc is far larger — about 7.4× 10X Genomics Inc's market cap, and Diamondback Energy Inc pays a 2.18% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| FANG | TXG | |
|---|---|---|
Market Cap | $56.48B | $7.61B |
Sector | Energy | Health |
52-Week High | $213.69 | $58.57 |
52-Week Low | $134.53 | $11.34 |
Enterprise Value | $68.63B | $7.14B |
Dividend Yield | 2.18% | — |
Trailing returns across standard periods
Latest headlines on both assets
Diamondback Energy is an independent oil and gas producer in the United States. The company operates exclusively in the Permian Basin. At the end of 2021, the company reported net proven reserves of 1.8 billion barrels of oil equivalent. Net production averaged about 375,000 barrels per day in 2021, at a ratio of 60% oil, 20% natural gas liquids, and 20% natural gas.
Read more on FANG →10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →